Literature DB >> 19117291

EGFR expression in primary squamous cell carcinoma of the thyroid.

Jennifer L Long1, Ali M Strocker, Marilene B Wang, Keith E Blackwell.   

Abstract

We present the case of a 57-year-old male with primary squamous cell carcinoma of the thyroid (PSCCT). Epidermal growth factor receptor (EGFR) staining was strongly positive. Pharmaceuticals targeting EGFR may provide an additional therapeutic option for this rare disease with extremely poor prognosis.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19117291     DOI： 10.1002/lary.20062

Source DB:  PubMed          Journal:  Laryngoscope        ISSN： 0023-852X            Impact factor:   3.325


  5 in total

1.  Metastatic tumours to the thyroid gland: report of 3 cases and brief review of the literature.

Authors:  Enver Vardar; Nazif Erkan; Umit Bayol; Cengiz Yılmaz; Murat Dogan
Journal:  Radiol Oncol       Date:  2010-09-22       Impact factor: 2.991

2.  Primary squamous cell carcinoma of the thyroid diagnosed as anaplastic carcinoma: failure in fine-needle aspiration cytology?

Authors:  Fernanda Bolfi; Maria A C Domingues; Manuel Sobrinho-Simões; Paula Soares; Ricardo Celestino; Emanuel C Castilho; Guareide Carelli; Norberto S Paes; Glaucia M F S Mazeto
Journal:  Case Rep Pathol       Date:  2014-09-09

3.  Primary squamous cell carcinoma of the thyroid: Case report and systematic review of the literature.

Authors:  Florian Struller; Moritz Senne; Claudius Falch; Andreas Kirschniak; Alfred Konigsrainer; Sven Muller
Journal:  Int J Surg Case Rep       Date:  2017-06-13

4.  HMGA1a recognition candidate DNA sequences in humans.

Authors:  Takayuki Manabe; Taiichi Katayama; Masaya Tohyama
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

5.  Less aggressive disease in patients with primary squamous cell carcinomas of the thyroid gland and coexisting lymphocytic thyroiditis.

Authors:  Mehmet Asik; Emine Binnetoglu; Hacer Sen; Fahri Gunes; Asli Muratli; Duygu Kankaya; Fatma Uysal; Mustafa Sahin; Kubilay Ukinc
Journal:  Contemp Oncol (Pozn)       Date:  2015-08-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.